Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Background: The cost-effectiveness acceptability curve (CEAC) is a method for summarizing the uncertainty in estimates of cost-effectiveness. The CEAC, derived from the joint distribution of costs and effects, illustrates the (Bayesian) probability that the data are consistent with a true cost-effectiveness ratio falling below a specified ceiling ratio. The objective of the paper is to illustrate how to construct and interpret a CEAC. Methods: A retrospective cost-effectiveness analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) randomized controlled trial with 4060 patients followed for 3.5 years. The target population was patients with atrial fibrillation who were 65 years of age or had other risk factors for stroke or death similar to those enrolled in AFFIRM. The intervention involved the management of patients with atrial fibrillation with antiarrhythmic drugs (rhythm-control) compared with drugs that control heart rate (rate-control). Measurements of mean survival, mean costs and incremental cost-effectiveness were made. The uncertainty surrounding the estimates of cost-effectiveness was illustrated through a cost-effectiveness acceptability curve. Results: The base case point estimate for the difference in effects and costs between rate and rhythm-control is 0.08 years (95% CI: -0.1 years to 0.24 years) and -US$5,077 (95% CI: -$1,100 to -$11,006). The CEAC shows that the decision uncertainty surrounding the adoption of rate-control strategies is less than 1.7% regardless of the maximum acceptable ceiling ratio. Thus, there is very little uncertainty surrounding the decision to adopt rate-control compared to rhythm-control for patients with atrial fibrillation from a resource point of view. Conclusion: The CEAC is straightforward to calculate, construct and interpret. The CEAC is useful to a decision maker faced with the choice of whether or not to adopt a technology because it provides a measure of the decision uncertainty surrounding the choice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Representing uncertainty: the role of cost‐effectiveness acceptability curves
Fenwick, E., Claxton, K., & Sculpher, M. (2001) · Health Economics · doi:10.1002/hec.635 · Cited by 1,110
Self-citationNet Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis
Stinnett, A. A., & Mullahy, J. (1998) · Medical Decision Making · doi:10.1177/0272989x98018002s09 · Cited by 1,102
Costs, effects and C/E‐ratios alongside a clinical trial
Van Hout, B. A., Al, M. J., Gordon, G. S., & Rutten, F. F. H. (1994) · Health Economics · doi:10.1002/hec.4730030505 · Cited by 964
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
Self-citationBriggs, A. H., Wonderling, D. E., & Mooney, C. Z. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199707)6:4<327::aid-hec282>3.0.co;2-w · Cited by 882
The CE Plane: A Graphic Representation of Cost-Effectiveness
Black, W. C. (1990) · Medical Decision Making · doi:10.1177/0272989x9001000308 · Cited by 581
Handling uncertainty when performing economic evaluation of healthcare interventions.
Briggs, & Gray (1999) · Health Technology Assessment · doi:10.3310/hta3020 · Cited by 387
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · Cited by 302
Definition, interpretation and calculation of cost-effectiveness acceptability curves
L�thgren, M., & Zethraeus, N. (2000) · Health Economics · doi:10.1002/1099-1050(200010)9:7<623::aid-hec539>3.0.co;2-v · Cited by 292
O’Brien, B. J., & Briggs, A. H. (2002) · Statistical Methods in Medical Research · doi:10.1191/0962280202sm304ra · Cited by 251
An Economic Evaluation of Activated Protein C Treatment for Severe Sepsis
Manns, B. J., Lee, H., Doig, C. J., Johnson, D., & Donaldson, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa020969 · Cited by 234
Cost Effectiveness of Lung-Volume–Reduction Surgery for Patients with Severe Emphysema
(2003) · New England Journal of Medicine · doi:10.1056/nejmsa030448 · Cited by 234
Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem
Willan, A. R., & OʼBrien, B. J. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199607)5:4<297::aid-hec216>3.0.co;2-t · Cited by 218
Chilcott, J., Miller, D. H., McCabe, C., Tappenden, P., O'Hagan, A., Cooper, N. J., Abrams, K., & Claxton, K. (2003) · BMJ · doi:10.1136/bmj.326.7388.522 · Cited by 142
Delaney, B. C., Wilson, S., Roalfe, A. K., Roberts, L. M., Redman, V., Wearn, A. M., Briggs, A. H., & Hobbs, R. F. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03308-0 · Cited by 124
Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation
Marshall, D. A., Levy, A. R., Vidaillet, H., Fenwick, E., Slee, A., Blackhouse, G., Greene, H. L., Wyse, D. G., Nichol, G., O'Brien, B. J., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-9-200411020-00005 · Cited by 113
Self-citationBYFORD, S., KNAPP, M., GREENSHIELDS, J., UKOUMUNNE, O. C., JONES, V., THOMPSON, S., TYRER, P., SCHMIDT, U., DAVIDSON, K., & ( POPMACT GROUP) (2003) · Psychological Medicine · doi:10.1017/s0033291703008183 · Cited by 85
Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
O’Hagan, A., Stevens, J., & Montmartin, J. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017040-00004 · Cited by 81
Sheldon, R. S., OʼBrien, B. J., Blackhouse, G., Goeree, R. A., Mitchell, B., Klein, G. J., Roberts, R. S., Gent, M., Connolly, S. J., & for the Canadian Implantable Defibrillator Study (CIDS) Investigators (2001) · Circulation · doi:10.1161/hc3901.096720 · Cited by 63
Bower, P., Byford, S., Barber, J., Beecham, J., Simpson, S., Friedli, K., Corney, R., King, M., & Harvey, I. (2003) · BMJ · doi:10.1136/bmj.326.7401.1247 · Cited by 50
Problems with Interval Estimates of the Incremental Cost—Effectiveness Ratio
Heitjan, D. F., Moskowitz, A. J., & Whang, W. (1999) · Medical Decision Making · doi:10.1177/0272989x9901900102 · Cited by 46
Briggs (1998) · doi:10.1002/(sici)1099-1050(199812)7:8
Cited by
Economic evaluation of a task-shifting intervention for common mental disorders in India
Buttorff, C., Hock, R., Weiss, H., Naik, S., Araya, R., Kirkwood, B., Chisholm, D., & Patel, V. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.12.104133 · Cited by 175
Creswell, C., Violato, M., Fairbanks, H., White, E., Parkinson, M., Abitabile, G., Leidi, A., & Cooper, P. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30149-9 · Cited by 126
Clare, L., Kudlicka, A., Oyebode, J. R., Jones, R. W., Bayer, A., Leroi, I., Kopelman, M., James, I. A., Culverwell, A., Pool, J., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23100 · Cited by 123
Hajek, P., Phillips-Waller, A., Przulj, D., Pesola, F., Smith, K. M., Bisal, N., Li, J., Parrott, S., Sasieni, P., Dawkins, L., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23430 · Cited by 72
Hamdani, S. U., Huma, Z.-E., Rahman, A., Wang, D., Chen, T., van Ommeren, M., Chisholm, D., & Farooq, S. (2020) · The British Journal of Psychiatry · doi:10.1192/bjp.2020.138 · Cited by 72
Metadata
- Authors
- Fenwick, E., Marshall, D. A., Levy, A. R., & Nichol, G.
- Venue
- BMC Health Services Research
- Published
- 2006-12
- Volume
- 6
- Issue
- 1
- Pages
- 52-52
- ISSN
- 1472-6963 (ISSN-L)
- OpenAlex
- W1562415841
- Cited by
- 279
- References
- 26
- FWCI
- 22.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.